152 Participants Needed

Understanding Physiological and Psychological Mechanisms in Eating Disorders

KJ
Overseen ByKatherine J Forney, PhD
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Ohio University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The proposed study tests fear, gut peptide response, and perceptions of fullness as causes of gastrointestinal distress and eating disorder maintenance.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment 'Test meal description changed' for eating disorders?

The study on food choice in eating disorders suggests that changes in meal composition, such as adjusting macronutrient intake, can influence psychological and temperamental aspects of eating disorders. This implies that altering meal descriptions could potentially impact eating behaviors and treatment outcomes.12345

How does this treatment for eating disorders differ from other treatments?

This treatment is unique because it focuses on understanding the physiological and psychological mechanisms in eating disorders, potentially involving stress response and autonomic nervous system (ANS) dysregulation, which are not typically addressed in standard treatments. It uses novel neuroimaging techniques and wearable devices to study these mechanisms, offering a more comprehensive approach to understanding and treating eating disorders.36789

Research Team

KJ

Katherine J Forney, PhD

Principal Investigator

Ohio University

Eligibility Criteria

This trial is for women aged 18-40 with a DSM-5 diagnosed eating disorder, feeling sick or having stomachaches after eating sometimes. They should have a BMI between 18.5 and 26.5 and experience significant distress or impairment from their condition. It's not for those with conditions affecting appetite/weight, recent/current pregnancy, dairy/strawberry/honey allergies, or specific blood-injection-injury phobias.

Inclusion Criteria

I am female.
Score 16 or higher on the Clinical Impairment Assessment
I am between 18 and 40 years old.
See 3 more

Exclusion Criteria

I have a condition that affects my appetite or weight.
Allergy to dairy, strawberry, or honey
Recent pregnancy or current breastfeeding
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants consume yogurt described as 'high fat' or 'low fat' during study visits to assess physiological and psychological responses

2 weeks
2 visits (in-person)

Assessment

Physiological and psychological measures are taken, including fear, gastrointestinal distress, and peptide responses

1 day
Multiple assessments within a single day

Follow-up

Participants are monitored for any delayed responses or effects post-intervention

4 weeks

Treatment Details

Interventions

  • Test meal description changed
Trial OverviewThe study examines how changing the description of a test meal affects fear responses, gut hormone levels, and feelings of fullness in individuals with eating disorders to understand gastrointestinal distress and maintenance of these disorders.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Low Fat Yogurt - High Fat YogurtExperimental Treatment1 Intervention
Participants will eat yogurt described as 'low fat' at Study Visit 2 and yogurt described as 'high fat' at Study Visit 3.
Group II: High Fat Yogurt - Low Fat YogurtExperimental Treatment1 Intervention
Participants will eat yogurt described as 'high fat' at Study Visit 2 and yogurt described as 'low fat' at Study Visit 3.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio University

Lead Sponsor

Trials
73
Recruited
17,800+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

The study aims to improve treatment for eating disorders (EDs) by developing personalized models that account for individual differences in symptoms and pathology, as up to 50% of individuals do not respond to standard Enhanced Cognitive-Behavioral Therapy (CBT-E).
By collecting data from 120 participants over 30 days using a mobile app and a sensor wristband, the research will identify specific behavioral and physiological targets that predict treatment outcomes and remission, potentially leading to more effective, tailored interventions.
Personalized networks of eating disorder symptoms predicting eating disorder outcomes and remission.Levinson, CA., Cash, E., Welch, K., et al.[2021]
The Eating Disorder Diagnostic Scale (EDDS) has demonstrated strong reliability and validity in a clinical population of 59 female patients with eating disorders, making it a useful tool for diagnosing conditions like anorexia nervosa and bulimia nervosa.
A cut-off score of 16.5 on the EDDS effectively differentiates clinical patients from healthy controls, indicating its potential application in clinical settings and research related to eating disorders.
The Eating Disorder Diagnostic Scale: psychometric features within a clinical population and a cut-off point to differentiate clinical patients from healthy controls.Krabbenborg, MA., Danner, UN., Larsen, JK., et al.[2022]
In a study of 124 female patients with various eating disorders, it was found that all patient groups had significantly lower intake of animal proteins compared to healthy controls, indicating a distinct alteration in food choices associated with these disorders.
The research also revealed that food choices in patients with eating disorders are correlated with psychological symptoms, suggesting that changes in nutrient intake may be influenced by underlying psychological and temperamental factors.
Food choice in disorders of eating behavior: correlations with the psychopathological aspects of the diseases.Segura-García, C., De Fazio, P., Sinopoli, F., et al.[2018]

References

Personalized networks of eating disorder symptoms predicting eating disorder outcomes and remission. [2021]
The Eating Disorder Diagnostic Scale: psychometric features within a clinical population and a cut-off point to differentiate clinical patients from healthy controls. [2022]
Food choice in disorders of eating behavior: correlations with the psychopathological aspects of the diseases. [2018]
Micro- and macroanalyses of patterns within a meal in anorexia and bulimia nervosa. [2007]
Sex differences in refeeding among hospitalized adolescents and young adults with eating disorders. [2023]
Neurobiological and psychopathological variables related to emotional instability: a study of their capability to discriminate patients with bulimia nervosa from healthy controls. [2015]
Direct experience while eating: Laboratory outcomes among individuals with eating disorders versus healthy controls. [2018]
The potential of calibrated fMRI in the understanding of stress in eating disorders. [2020]
Toward Quantifying the Psychopathology of Eating Disorders From the Autonomic Nervous System Perspective: A Methodological Approach. [2023]